Meeting
2020 Gastrointestinal Cancers Symposium
Increased frequency of PD-1+CD57+Siglec-7- dysfunctional NK cells in patients with nonalcoholic fatty liver disease.
Authors
Yuzuru Sakamoto
Department of Gastoenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Yuzuru Sakamoto , Sachiyo Yoshio , Akihisa Nagatsu , Yoh Asahi , Shingo Shimada , Tatsuya Orimo , Hirofumi Kamachi , Toshiya Kamiyama , Tatsuya Kanto , Akinobu Taketomi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Other
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 589)
Abstract #
589
Poster Bd #
F6
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
A first-in-class ex vivo combination between cytokine-induced memory like (CIML) NK cells and a CD38 targeting antibody recruiting molecule (ARM) as a novel approach to target NK cells without cellular engineering for the treatment of multiple myeloma.
First Author: Luca Rastelli
Poster
2022 ASCO Annual Meeting
AdvanTIG-206: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (BGB-A1217; OCI) plus anti-programmed cell death protein-1 (PD-1) mAb tislelizumab (TIS) plus BAT1706 versus TIS plus BAT1706 as first-line (1L) treatment for advanced hepatocellular carcinoma (HCC).
First Author: Jia Fan
Poster
2022 ASCO Gastrointestinal Cancers Symposium
AdvanTIG-206: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (BGB-A1217; OCI) plus anti-programmed cell death protein 1 (PD-1) mAb tislelizumab (TIS) plus BAT1706 versus (vs) TIS plus BAT1706 as first-line treatment for advanced hepatocellular carcinoma (HCC).
First Author: Jia Fan
Poster
2024 ASCO Annual Meeting
Association of circulating T lymphocytes and their functional states with pathologic complete response (pCR) in breast cancer (BC). A prospective Italian study.
First Author: Rahma Ben Ayed